From £900
Full genomic sequencing & hereditary risk profiling
From £290
Condition-specific panels ordered on clinical indication
Genetic Testing
Standard health screening tells you where you are now. Genetic testing tells you what your biology is predisposed toward — years or decades before symptoms emerge.
​
Reborne offers a comprehensive suite of genomic diagnostics, from whole-genome sequencing and polygenic risk scoring to pharmacogenomics, nutrigenomics, and multi-cancer liquid biopsy. Every test is ordered on clinical indication, interpreted by your physician with full context, and used to build a precision medicine protocol specific to your biology. Every test is ordered on clinical indication and interpreted within the full context of your biology — not forwarded as a report and left without meaning.
Our Tests
Tests Available at Reborne
The right test depends on your clinical history, goals, and what your physician determines is most actionable for your biology. Below is the full menu of genomic diagnostics available at Reborne — each ordered on indication and interpreted in full clinical context.
Whole-genome or targeted sequencing to detect hereditary disease risk, monogenic variants, and pharmacogenomic markers across the full genome. Results are presented in a structured clinical report, with your physician discussing every clinically actionable finding directly. Includes BRCA1/2, Lynch syndrome, and other hereditary cancer and disease variants where relevant.
​
From £900
Analyses hundreds of thousands of genetic variants simultaneously to calculate your cumulative lifetime risk for complex conditions — cardiovascular disease, metabolic disorders, and cancer. Where standard genetic testing reads individual variants, polygenic scoring reads the full genetic landscape. Individuals at high polygenic risk may carry three to five times the population-average lifetime risk for a condition, even with no symptoms or abnormal blood tests.
​
£2,975
Analyses the genetic variants that determine how your body responds to specific nutrients, vitamins, and dietary patterns — covering folate metabolism (MTHFR), vitamin D receptor sensitivity (VDR), omega-3 utilisation (FADS1/2), caffeine metabolism (CYP1A2), and antioxidant defence (SOD2). Our cellular nutrient analysis complements this by quantifying your actual functional nutrient levels through advanced biomarker testing, ensuring your supplementation protocol is matched precisely to both your genetics and your current biology.
From £499Identifies how your genome affects drug metabolism — including CYP450 enzyme activity across CYP2D6, CYP2C19, CYP2C9, and CYP3A4. Enables precise medication selection and adjusted dosing, minimising adverse reactions and maximising therapeutic outcome. Particularly relevant for psychiatric medications, anticoagulants, pain management, and cardiovascular prescribing.
​
From £499
Condition-specific panels covering cardiovascular disease, oncology risk, neurodegeneration (including ApoE4), thrombophilia, and more. Ordered on clinical indication. Results presented with full clinical context — every finding explained and translated into a recommended action.
From £290Identifies delayed immune responses to foods, chemicals, and environmental triggers. Analyses IgG and IgG4-mediated reactivity across 132 foods, additives, and colourants. Pinpoints the dietary drivers of systemic inflammation, gut dysfunction, and chronic symptoms including fatigue, brain fog, and skin conditions.
​
£300
Full sequencing of your gut microbiome to assess bacterial diversity, dysbiosis, and microbial influence on metabolic, immune, and neurological function. Findings are integrated directly into your clinical protocol.
​
£478
Identifies circulating tumour cells across multiple cancer types from a single blood draw, with tissue of origin characterisation. Offered within a framework including physician-led pre-test consultation and a structured positive-result pathway. Early-stage cancer is almost always more treatable — this test extends the detection window to cancers for which no routine screening currently exists.
£1,500
Why Genetics Matters
Why Genetics Matters in Longevity Medicine
Your genome is the most stable dataset in your biology. It does not change with stress, sleep, or diet — and it encodes a substantial proportion of your lifetime risk for the conditions that will most influence how you age. Understanding this landscape early is not about determinism. It is about intelligent, targeted action: intervening before the risk materialises.
​
At Reborne, genetic results are integrated with your blood biomarkers, body composition data, clinical history, and functional testing to form a single, coherent biological picture — one that informs every subsequent clinical decision.
Why Cortisol MatterS
The Complete Cortisol Picture
A standard blood test measures cortisol at a single moment - one point on a curve that changes throughout the day. In a healthy pattern, cortisol rises within 30 - 45 minutes after waking, peaks in the morning, and gradually declines. This early rise, known as the cortisol awakening response, is a key marker of how your stress system is functioning, yet it is not captured in routine testing.
Our in-depth assessment measures cortisol at multiple points across the day using a simple at-home collection, allowing us to see your full daily rhythm. It also measures cortisone and cortisol metabolites, providing insight into how your body produces, regulates, and clears cortisol, and your overall adrenal activity.
How We Work
Genetics Interpreted Through a Clinical Lens
At Reborne Longevity, every diagnostic is integrated into a physician-led clinical framework designed around you. Every test begins with a consultation to determine which investigations are genuinely relevant to your biology, symptoms, goals, and risk profile. Once results are available, you meet with a clinician who explains every finding in detail, contextualising the data and translating it into a clear, actionable health strategy.
Precision Genomics
Begin With Your Genome
Genetic testing at Reborne is ordered on clinical indication, interpreted in full context by your physician, and used to build a precision intervention protocol specific to your unique biology. Every result comes with a clear, actionable plan.
​
Your initial consultation is fully redeemable against any diagnostic test or programme. No client undergoes genetic testing at Reborne without a prior clinical assessment confirming the appropriate tests for their history, goals, and current health status.